DK1093369T3 - Middel med antidepressiv virkning indeholdende pramipexol og sertralin - Google Patents

Middel med antidepressiv virkning indeholdende pramipexol og sertralin

Info

Publication number
DK1093369T3
DK1093369T3 DK99934560T DK99934560T DK1093369T3 DK 1093369 T3 DK1093369 T3 DK 1093369T3 DK 99934560 T DK99934560 T DK 99934560T DK 99934560 T DK99934560 T DK 99934560T DK 1093369 T3 DK1093369 T3 DK 1093369T3
Authority
DK
Denmark
Prior art keywords
sertraline
containing pramipexole
antidepressant containing
antidepressant
pramipexole
Prior art date
Application number
DK99934560T
Other languages
Danish (da)
English (en)
Inventor
Jerzy Maj
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1093369T3 publication Critical patent/DK1093369T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99934560T 1998-07-07 1999-07-02 Middel med antidepressiv virkning indeholdende pramipexol og sertralin DK1093369T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830201A DE19830201A1 (de) 1998-07-07 1998-07-07 Mittel mit antidepressiver Wirkung
PCT/EP1999/004595 WO2000002542A2 (de) 1998-07-07 1999-07-02 Mittel mit antidepressiver wirkung, enthaltend pramipexol und ein weiteres antidepressivum

Publications (1)

Publication Number Publication Date
DK1093369T3 true DK1093369T3 (da) 2002-12-16

Family

ID=7873155

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99934560T DK1093369T3 (da) 1998-07-07 1999-07-02 Middel med antidepressiv virkning indeholdende pramipexol og sertralin

Country Status (32)

Country Link
US (1) US6255329B1 (sr)
EP (1) EP1093369B1 (sr)
JP (1) JP2002520273A (sr)
KR (1) KR100557692B1 (sr)
CN (1) CN1230168C (sr)
AR (1) AR019896A1 (sr)
AT (1) ATE228365T1 (sr)
AU (1) AU762128B2 (sr)
BG (1) BG64972B1 (sr)
BR (1) BR9911768A (sr)
CA (1) CA2336833C (sr)
CZ (1) CZ294087B6 (sr)
DE (2) DE19830201A1 (sr)
DK (1) DK1093369T3 (sr)
EA (1) EA003142B1 (sr)
EE (1) EE04296B1 (sr)
ES (1) ES2183583T3 (sr)
HU (1) HUP0103922A3 (sr)
ID (1) ID27776A (sr)
IL (1) IL140603A0 (sr)
MY (1) MY117969A (sr)
NO (1) NO20010064L (sr)
NZ (1) NZ509729A (sr)
PL (1) PL195043B1 (sr)
PT (1) PT1093369E (sr)
RS (1) RS49795B (sr)
SK (1) SK284923B6 (sr)
TR (1) TR200100146T2 (sr)
TW (1) TW592698B (sr)
WO (1) WO2000002542A2 (sr)
YU (1) YU401A (sr)
ZA (1) ZA200100090B (sr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006162A1 (de) * 1998-07-27 2000-02-10 Boehringer Ingelheim Pharma Kg Mittel mit antidepressiver wirkung, mit pramipexol und einem weiteren antidepressivum
WO2002069974A1 (en) * 2001-03-05 2002-09-12 Andrew Holman Administration of sleep restorative agents
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
MXPA04005572A (es) * 2001-12-11 2004-12-06 Univ Virginia Uso de pramipexol para tratamiento de esclerosis lateral amiotrofica.
US20060281797A1 (en) * 2001-12-11 2006-12-14 University Of Virginia Patent Foundation Neurorestoration with R(+) Pramipexole
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
WO2005070428A1 (en) * 2004-01-22 2005-08-04 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
US20080234338A1 (en) * 2005-08-15 2008-09-25 University Of Virginia Patent Foundation Neurorestoration With R(+) Pramipexole
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
KR20090021169A (ko) 2006-05-16 2009-02-27 크놉 뉴로사이언시스 인코포레이티드 Ｒ(+) 및 ｓ(-) 프라미펙솔을 포함하는 조성물 및 이의 사용 방법
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
CN101715443A (zh) 2007-03-14 2010-05-26 诺普神经科学股份有限公司 手性纯化的取代的苯并噻唑二胺的合成
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
US20110190356A1 (en) * 2008-08-19 2011-08-04 Knopp Neurosciences Inc. Compositions and Methods of Using (R)- Pramipexole
EP2341912B1 (en) 2008-09-05 2014-01-22 Supernus Pharmaceuticals, Inc. Method of treatment of attention deficit/hyperactivity disorder (adhd)
AU2010242971A1 (en) * 2009-04-30 2011-11-24 Supernus Pharmaceuticals, Inc. Method of treatment of depression
WO2013096816A1 (en) 2011-12-22 2013-06-27 Biogen Idec Ma Inc. Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
AU2013217013B2 (en) 2012-02-08 2017-04-20 Supernus Pharmaceuticals, Inc. Modified release formulations of viloxazine
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
ES3043076T3 (en) 2013-07-12 2025-11-24 Areteia Therapeutics Inc Treating elevated levels of eosinophils and/or basophils
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
ES2871556T3 (es) 2013-08-13 2021-10-29 Knopp Biosciences Llc Composiciones y métodos para el tratamiento de la urticaria crónica
WO2015023786A1 (en) 2013-08-13 2015-02-19 Knopp Biosciences Llc Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
IL312486B2 (en) * 2017-04-10 2025-05-01 Chase Therapeutics Corp NK1 antagonist combination and method for treating synucleinopathies
IL271464B2 (en) 2017-06-30 2024-08-01 Chase Therapeutics Corp NK-1 antagonist compositions and methods for use in the treatment of depression
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
DE3572485D1 (en) * 1984-12-22 1989-09-28 Thomae Gmbh Dr K Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
JP3947582B2 (ja) * 1995-08-15 2007-07-25 中外製薬株式会社 不安神経症治療剤
CN1128788C (zh) * 1996-03-29 2003-11-26 辉瑞大药厂 苄基(亚苄基)－内酰胺衍生物,它们的制备以及作为5－ht1a和/或5－ht1d受体的选择性拮抗剂(激动剂)的用途
EP0942732B1 (en) * 1996-12-02 2004-11-17 MERCK SHARP & DOHME LTD. Use of nk-1 receptor antagonists for treating movement disorders
EP1047436B1 (en) * 1998-01-13 2009-10-21 Synchroneuron, LLC N-acetylhomotaurinates for use in treating hyperkinesias

Also Published As

Publication number Publication date
CA2336833C (en) 2008-09-23
EE200100014A (et) 2002-06-17
WO2000002542A3 (de) 2000-06-22
ZA200100090B (en) 2002-04-04
TR200100146T2 (tr) 2001-07-23
BG64972B1 (bg) 2006-11-30
BR9911768A (pt) 2001-04-03
CA2336833A1 (en) 2000-01-20
RS49795B (sr) 2008-06-05
BG105112A (bg) 2001-10-31
EA200100084A1 (ru) 2001-08-27
SK284923B6 (sk) 2006-02-02
KR100557692B1 (ko) 2006-03-07
PT1093369E (pt) 2003-03-31
DE19830201A1 (de) 2000-01-13
WO2000002542A2 (de) 2000-01-20
IL140603A0 (en) 2002-02-10
HK1037976A1 (en) 2002-03-01
EA003142B1 (ru) 2003-02-27
CZ294087B6 (cs) 2004-10-13
EP1093369B1 (de) 2002-11-27
ATE228365T1 (de) 2002-12-15
ES2183583T3 (es) 2003-03-16
SK112001A3 (en) 2001-10-08
US6255329B1 (en) 2001-07-03
CN1230168C (zh) 2005-12-07
AR019896A1 (es) 2002-03-20
PL195043B1 (pl) 2007-08-31
TW592698B (en) 2004-06-21
KR20010079491A (ko) 2001-08-22
AU5030399A (en) 2000-02-01
NO20010064D0 (no) 2001-01-05
ID27776A (id) 2001-04-26
HUP0103922A2 (hu) 2002-03-28
AU762128B2 (en) 2003-06-19
PL345842A1 (en) 2002-01-14
CN1308533A (zh) 2001-08-15
HUP0103922A3 (en) 2002-08-28
EE04296B1 (et) 2004-06-15
NO20010064L (no) 2001-03-02
NZ509729A (en) 2003-06-30
CZ200177A3 (en) 2001-06-13
DE59903556D1 (de) 2003-01-09
JP2002520273A (ja) 2002-07-09
EP1093369A2 (de) 2001-04-25
YU401A (sh) 2003-10-31
MY117969A (en) 2004-08-30

Similar Documents

Publication Publication Date Title
PT1093369E (pt) Agente de efeito antidepressivo contendo pramipexole e sertralina
DK0996444T3 (da) Behandling af diabetes med thiazolidindion og metformin
NO20006062L (no) Innkapslede brytere, blandinger og fremgangsmåte for anvendelse derav
NO20022334L (no) Ny sammensetning og anvendelse
DK1224297T3 (da) Alzheimers sygdom -sekretase, APP-substrater derfor og anvendelser deraf
NL1016224A1 (nl) Foto-basevormend middel en foto-zuurvormend middel bevattende foto- etssamenstelling.
NO20022289L (no) Ny anvendelse og nye N-azabisykloamidderivater
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
DE69913128D1 (de) Teilweise blockverschachtelte cdma-kodierung und dekodierung
FI981614L (fi) Laakerin kunnon evakuointi
DK1112003T3 (da) Ny sammensætning og anvendelse
NO20011157D0 (no) Benzenderivater og farmasøytisk anvendelse derav
DE59905437D1 (de) Toner und/oder Toner-Mischungen
DE60117046D1 (de) Kombination von fenofibrat und von coenzym q10 für die behandlung der endotheliaal missfunktion
NO20003916L (no) Benzotiadiazoler og derivater
NO20005173D0 (no) Gen som koder for heliomicin og anvendelse derav
IS5942A (is) 3,3-bíarýlpíperidín og 2,2-bíarýlmorfólín afleiður
NO20003601D0 (no) Nye naftyl-substituerte og anilid-substituerte sulfonamider
NO20003595L (no) Desintegrerende middel
DE69904279D1 (de) Aromatisches Polycarbodiimid und Polycarbodiimidfolie
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
NO20021612D0 (no) Karbonylstressreduserende middel
ATE223666T1 (de) Drehbarer schmuckring
DE60023918D1 (de) MODIFIZIERTE CDNA DES bcl-x GENS DER RATTE UND MODIFIZIERTES PROTEIN
DE60041158D1 (de) Fixier- und/oder Zwischenübertragungstrommel